Egypt’s Minister of State for Military Production, Salah Gamblat, witnessed the signing of a cooperation protocol between the National Authority for Military Production and Barox, the Turkish company specialising in hyperbaric oxygen therapy systems.
Gamblat said the agreement reflects the state’s vision to strengthen local manufacturing by engaging the private sector and attracting foreign investment. He noted that Barox is among the world’s leading producers of hyperbaric oxygen therapy chambers and systems.
The protocol aims to transfer Barox’s expertise and localise the production of hyperbaric devices within Egypt’s military factories, leveraging advanced manufacturing lines and qualified capacities. Local production is intended to meet the needs of hospitals in Egypt and across Africa, in line with directives from the political leadership to deepen industrial localisation, modernise technology, and reduce the import bill.
Gamblat highlighted that hyperbaric devices are vital therapeutic tools used in treating a wide range of medical conditions, including carbon monoxide poisoning, chronic wounds, soft tissue infections, osteomyelitis, diabetic ulcers, sports injuries, acute oxygen deficiency, certain cancers, middle ear infections, skin diseases, and some autism spectrum disorder cases.
Barox expressed pride in partnering with the Ministry of Military Production, praising its industrial capabilities and role as a leading national institution supporting Egyptian industry.
Both sides affirmed that the cooperation will serve as a platform for exchanging scientific and industrial expertise, advancing sustainable development goals, and strengthening national human resources to keep pace with rapid technological change, particularly in innovation and digital transformation.
